Final exam pharm question - Study guides, Class notes & Summaries

NU 425 PHARM PSYCH FINAL STUDY GUIDE EXAM QUIZ WITH VERIFIED ANSWERS i. A patient’s wandering and hostility levels have increased per family reports. What should concern thenurse in this patient who is taking memantine (Namenda) 10 mg/d? - The patient is not taking enough of the medication ii.What statement by the patient indicates an understanding of how to relieve some side effectsassociated with the use of benzotropine mesylate (Cogentin)? “I can suck on hard candy or chew sugarle...

Criteria *Critical Assignments (where applicable) If a student achieves 76% or more on each Critical Assignment, then the grades earned on the remaining course assignments will be included in the final course grade. If a critical assignment has multiple submissions, i.e. concept maps or weekly clinical reports, must achieve a 76% average grade to pass. If a student achieves less than 76% on the Critical Assignments, then the grades earned on the remaining course assignments will not be incl...

MSN 611 PHARM FINAL EXAM (100 OUT OF 100) QUESTIONS AND VERIFIED ANSWERS | RATED A

Pharm Final 100 Questions With Correct Answers 1. A nurse is monitoring a client who is receiving Epoetin alfa for adverse effects. The nurse should identify which of the following findings as an adverse effect of this medication? a. Edema and hematuria b. Blurred vision and edema c. Urinary retention and abdominal pain d. Hypertension and headache - answerD. Hypertension and headache. 2. A patient with Parkinson's disease is taking levodopa/carbidopa [Sinemet] and reports occasiona...

NU 425 PHARM PSYCH FINAL STUDY GUIDE EXAM QUIZ WITH VERIFIED ANSWERSNU 425 PHARM PSYCH FINAL STUDY GUIDE EXAM QUIZ WITH VERIFIED ANSWERS i. A patient’s wandering and hostility levels have increased per family reports. What should concern thenurse in this patient who is taking memantine (Namenda) 10 mg/d? - The patient is not taking enough of the medication ii.What statement by the patient indicates an understanding of how to relieve some side effectsassociated with the use of benzotro...

NR 508 ADVANCED PHARM. FINAL EXAM 2023 NEW (JAN-JULY TERM) PRIORITY FULL EXAM WITH RATIONALES 100% CORRECT. NR 508 Final Exam Question 1 2 / 2 pts A patient who has diabetes reports intense discomfort when needing to void. A urinalysis is normal. To treat this, the primary care NP should consider prescribing: flavoxate (Urispas). bethanechol (Urecholine). phenazopyridine (Pyridium). Correct! oxybutynin chloride (Ditropan XL). This patient is describing urge incontinence, o...

Nursing MSN 571 Pharm Midterm and Final Exam Questions with 100% Correct Answers Latest Updated 2024/2025 (GRADED A+) What intervention does the provider take to decrease risk to the patient when prescribing drugs with a narrow therapeutic index? -ANS-- drugs with narrow therapeutic range are more dangerous, provider who is aware of this fact can focus additional attention on monitoring these patients for signs and symptoms of toxicity definition of onset of action -ANS-- Onset of Action: t...

Pharm Final Exam Question Bank VERIFIED Q AND A. Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 5th edition Woo Robinson Test Bank Chapter 18. Drugs Affecting the Endocrine System: Pancreatic Hormones and Antidiabetic Drugs 1. Both men and women experience bone loss with aging. The bones most likely to demonstrate significant loss are: a. Cortical bones b. Femoral neck bones c. Cervical vertebrae d. Pelvic bones 2. Bisphosphonates treat or prevent osteoporosis by: a. Inhibiting os...

NSG 6005 PHARM FINAL EXAM 1 – QUESTION WITH ANSWERS

PHARM FINAL MN553 LATEST WITH 200 REAL EXAM QUESTIONS AND CORRECT ANSWERS (VERIFIED ANSWERS) A+GRADE 1. If a patient with symptoms of gastro esophageal reflux disease states that he has been self-treating at home with OTC ranitidine daily, the appropriate treatment would be: Question options: Prokinetic (metoclopramide) for 4 to 8 weeks Proton pump inhibitor (omeprazole) for 12 weeks Histamine2 receptor antagonist (ranitidine) for 4 to 8 weeks Cytoprotective drug (misoprostol) fo...